Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Normix

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 233Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    US Court rules in favor of FDA, Salix, Teva, against Norwich
    US Court rules in favor of FDA, Salix, Teva, against Norwich

    17 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/us-district-court-grants-summary-judgment-in-favor-of-fda-salix-and-t-1016430

    ACCESSWIRE
    17 Apr 2025
    Share Share
    Bausch's Xifaxan Chosen For Inflation Reduction Act Medicare
    Bausch's Xifaxan Chosen For Inflation Reduction Act Medicare

    17 Jan 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bausch-health-statement-on-selection-of-xifaxanrifaximin-for-inflation-reduction-acts-medicare-negotiation-program-969865

    ACCESSWIRE
    17 Jan 2025
    Share Share
    Amneal`s Generics Rifaximin Receives Tentative Approval in US
    Amneal`s Generics Rifaximin Receives Tentative Approval in US

    16 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218862

    FDA
    16 Jan 2025
    Share Share
    Supreme Court Declines Patent Dispute Over Bausch Diarrhea Drug
    Supreme Court Declines Patent Dispute Over Bausch Diarrhea Drug

    18 Nov 2024

    // REUTERS

    https://www.reuters.com/legal/us-supreme-court-declines-hear-patent-dispute-over-bausch-blockbuster-diarrhea-2024-11-18/

    REUTERS
    18 Nov 2024
    Share Share
    Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
    Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals

    20 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=879900&lang=en

    ACCESSWIRE
    20 Jun 2024
    Share Share
    Norwich Pharmaceuticals Generic Rifaximin Receives Tentative Approval in US
    Norwich Pharmaceuticals Generic Rifaximin Receives Tentative Approval in US

    20 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214369

    FDA
    20 Jun 2024
    Share Share